Your browser doesn't support javascript.
loading
Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome.
Lakomy, Tim; Akhoundova, Dilara; Nilius, Henning; Kronig, Marie-Noëlle; Novak, Urban; Daskalakis, Michael; Bacher, Ulrike; Pabst, Thomas.
Afiliação
  • Lakomy T; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, 3012 Bern, Switzerland.
  • Akhoundova D; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, 3012 Bern, Switzerland.
  • Nilius H; University Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
  • Kronig MN; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, 3012 Bern, Switzerland.
  • Novak U; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, 3012 Bern, Switzerland.
  • Daskalakis M; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
  • Bacher U; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
  • Pabst T; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, 3012 Bern, Switzerland.
Biomolecules ; 13(2)2023 02 17.
Article em En | MEDLINE | ID: mdl-36830750

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Síndrome da Liberação de Citocina Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Biomolecules Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Síndrome da Liberação de Citocina Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Biomolecules Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça